STIL, a neurotechnology startup from Delft, has secured €2 million to expand its team and clinical partnerships, accelerating its market presence. The company addresses essential tremors affecting over 30 million individuals globally through its innovative anti-tremor orthosis. This CE-marked device reduces tremors by over 80%, allowing individuals to regain control in everyday activities without the invasiveness of surgery or pharmaceuticals. Founded by IJsbrand de Lange and Nicola Pambakian, STIL aims to improve quality of life for those suffering from essential tremors, dystonia, and Parkinson's disease, establishing distribution in multiple European countries.
STIL's innovative anti-tremor orthosis effectively reduces forearm tremors by over 80%, enabling greater independence and ease in daily activities for sufferers.
The STIL orthosis employs specialized dampers to suppress involuntary tremors without restricting voluntary motion, providing instant relief and restoring patient autonomy.
Collection
[
|
...
]